Skip to content

FuLvning Decoction in the Treatment of Atrial Fibrillation Patient with Deficiency of Qi and Yin: a Randomized, Double-Blind Controlled Trial

FuLvning Decoction in the Treatment of Atrial Fibrillation Patient with Deficiency of Qi and Yin: a Randomized, Double-Blind Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036835
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 85 years; 2. paroxysmal atrial fibrillation, frequency of onset >=2 times/month or persistent atrial fibrillation (at least one electro cardiogram diagnosis); 3. TCM syndrome differentiation and typing is qi-yin deficiency type; 4. Have a correct understanding of the significance of the study, good compliance with the observation and evaluation of the researchers, voluntary clinical trials and fill in consent form.

Exclusion criteria

Exclusion criteria: 1. A patient with severe lung, liver, renal insufficiency, hematopoietic system or severe cardiac dysfunction (grade NYHA IV); 2. Mental illness and poor control; 3. Patients with heart rate less than 50 beats per minute (e.g. sick sinus syndrome, atrioventricular or chamber block, pacemakers to be installed); 4. Pregnant or lactating women; 5. End-stage cachexia in malignant tumors.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine score;the improvement of palpitation frequency and cumulative seizure time after treatment ;

Secondary

MeasureTime frame
ECG;Holter;Echocardiography;The rate of increase or decrease of western medicines to transfer to the law and to control the room law;Evaluation of Hamilton Anxiety and Depression Scale;SF-36 EVALUATION;Amino-terminal brain natriuretic peptide (NT-proBNP);

Countries

China

Contacts

Public ContactQiong Wu

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

wuqiong1203@126.com+86 18917047505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026